Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial
Bloomberg
Fri, 04/1/11 - 11:32 am
Tags:
Roche
,
Curis
,
skin cancer
,
vismodegib
Dividend Sector Review: Pharmaceuticals
Motley Fool
Thu, 03/31/11 - 10:15 pm
Tags:
dividends
,
Eli Lilly
,
GSK
,
AstraZeneca
,
Roche
,
Merck
,
Novartis
,
Abbott Laboratories
,
Pfizer
,
JNJ
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom
In-Pharm
Wed, 03/30/11 - 11:41 am
Tags:
Roche
,
M&A
,
Novartis
Roche will not be for sale, vice chmn tells paper
Reuters
Mon, 03/28/11 - 11:43 am
Tags:
Roche
,
M&A
What Biotech Wants From Big Pharma Partners: Survey Says!?
InVivo
Wed, 03/23/11 - 10:29 am
Tags:
Big Pharma
,
biotech
,
Roche
,
Merck
,
GSK
,
Novartis
,
Pfizer
,
Eli Lilly
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tue, 03/22/11 - 11:07 am
Tags:
Novartis
,
Gilenya
,
MS
,
multiple sclerosis
,
Teva Pharmaceuticals
,
Biogen Idec
,
Roche
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
Tags:
ASCO
,
Medivation
,
Exelixis
,
Dendreon
,
Bristol-Myers Squibb
,
Roche
,
Curis
,
Celgene
,
Sanofi
,
Ariad Pharmaceuticals
,
Merck
,
Incyte
,
Novartis
,
YM BioSciences
,
Pfizer
,
Aveo Pharmaceutical
,
ONYX Pharmaceuticals
,
Amgen
,
Synta
,
Vical
,
Oxigene
,
Cell Therapeutics
,
Oncothyreon
Roche, Curis Skin Cancer Drug Advances
TheStreet.com
Mon, 03/21/11 - 11:25 am
Tags:
skin cancer
,
Roche
,
Curis
Roche acquires PVT to strengthen diagnostics unit
Pharma Times, UK
Wed, 03/16/11 - 10:46 am
Tags:
Roche
,
diagnostics
,
M&A
,
PVT
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tue, 03/15/11 - 12:31 pm
Tags:
Alzheimer's disease
,
Razadyne
,
Nivalin
,
Ortho-McNeil-Janssen
,
Exelon
,
Novartis
,
Aricept
,
Eisai
,
Pfizer
,
Namenda
,
Merz
,
Forest Labs
,
Eli Lilly
,
Elan
,
JNJ
,
Roche
,
MorphoSys
Roche's Eye Drug Impresses
Yahoo/Zacks
Sat, 03/12/11 - 01:27 pm
Tags:
Roche
,
Lucentis
,
diabetic macular edema
All Eyes Are On Roche, Avastin And Lucentis
Pharmalot
Fri, 03/4/11 - 01:03 pm
Tags:
Roche
,
Avastin
,
Lucentis
,
diabetic macular edema
OraSure Technologies and Roche Announce FDA 510(k) Clearance for Four Fully Automated Oral Fluid Drugs of Abuse Assays
Yahoo/Globe Newswire
Thu, 03/3/11 - 10:50 am
Tags:
OraSure
,
Roche
,
diagnostics
,
drug abuse
,
INTERCEPT
Avastin gets to keep its breast cancer use in Europe
Fierce Pharma
Wed, 03/2/11 - 12:01 pm
Tags:
Avastin
,
breast cancer
,
Europe
,
Roche
Roche’s ‘Brilliant Concept’ Fades Amid Doctor Disappointment
Bloomberg
Wed, 02/23/11 - 08:15 am
Tags:
Roche
,
Avastin
,
cancer
Bone Drugs by Merck, Roche, Novartis May Add Leg Fractures
Bloomberg
Tue, 02/22/11 - 05:56 pm
Tags:
Merck
,
Roche
,
Novartis
,
osteoporosis
,
bisphosphonates
,
Boniva
,
Reclast
,
Fosamax
Which Sales Reps Rank Highest With Oncologists?
Pharmalot
Tue, 02/22/11 - 10:36 am
Tags:
drug reps
,
oncologists
,
Roche
,
Genentech
,
Novartis
Should FDA Hit The Brakes On Accelerated Approval?
Pharmalot
Wed, 02/9/11 - 11:54 am
Tags:
FDA
,
Roche
,
Avastin
,
breast cancer
,
Pfizer
,
AML
FDA Says Drug Firms Didn't Finish Follow-Ups
WSJ Online
Wed, 02/9/11 - 11:16 am
Tags:
FDA
,
cancer
,
Roche
,
GSK
,
Eli Lilly
,
AstraZeneca
,
Amgen
New York's Medicaid program gives Roche glucose monitors the boot
Mass Device
Tue, 02/8/11 - 08:12 pm
Tags:
New York
,
Medicaid
,
Roche
,
blood glucose monitoring
Pages
« first
‹ previous
…
97
98
99
100
101
102
103
104
105
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.